US Pharmaceutical Drug Delivery Market Size Likely to Surpass at a CAGR of 5.12% By 2034

As per the US Pharmaceutical Drug Delivery Market size analysis conducted by the CMI Team, the US pharmaceutical drug delivery market is expected to record a CAGR of 5.12% from 2025 to 2034. In 2025, the market size was USD 680.25 Billion. By 2034, the valuation is anticipated to reach USD 1097.98 Billion.

US Pharmaceutical Drug Delivery Market Overview

As per the industry experts at CMI, the US Pharmaceutical Drug Delivery Market will witness substantial growth due to rising incidences of chronic ailments, adoption of technological advancements in drug delivery, and growing inclination toward home healthcare.

As per the International Agency for Research on Cancer, in the year 2020, close to 19.3 million novel cancer cases with 10 million cancer fatalities were recorded around the world. It further states that close to 28.4 million new cancer cases would be recorded at the global level in 2040. As per the WHO, cardiovascular diseases account for 32% of deaths worldwide.

According to the International Diabetes Federation, the diabetic population worldwide is likely to reach 783 million by the year 2045. The fact that the incidences of these diseases are growing at an alarming rate is bound to augment the US pharmaceutical drug delivery market in the forecast period, as research states that over 60% of the US population is battling atleast one chronic disease.

US Pharmaceutical Drug Delivery Market Growth Factors and Dynamics

• Injectable Drug Delivery on the Move: Injectable drug delivery devices are precise, convenient, and patient-centric. Auto-injectors and prefilled syringes are adding to safety and compliance. The manufacturers are thus provided with a huge opportunity to provide user-specific delivery solutions for the self-administered drugs. Biologic injectors are in great demand on the similar front.

• Delivering Drugs the Smart Way: Smart drug delivery systems, through wearable technologies and IoT, make it simple to adjust the dosages and customized treatment regimens that aid patients in following prescribed therapy. The digital health as well as patient-oriented care solutions are gaining popularity. As such, adoption on their part is also on the rise.

Report Scope

US Pharmaceutical Drug Delivery Market SWOT Analysis

• Strengths: Advanced drug delivery system and nanotechnology are improving drug efficacy and driving innovation. Rise in the geriatric population coupled with the growing demand for home healthcare is boosting the market. Furthermore, controlled release systems are surpassing conventional limitations and enhancing patient outcomes.

• Weaknesses: Development of drugs could be costly, thereby impacting the accessibility and affordability. Plus, there ought to be regulatory hurdles along with compliance requirements, which could be time-consuming and challenging. Biosimilars and generic drugs are also exerting pressure on profitability.

• Opportunities: The ongoing trend of self-administration creates possibilities regarding innovative drug delivery services. Also, customizing drug delivery to the individual needs of patients through targeted therapies could improve outcomes and increase the mindshare of the end-users.

• Threats: Pressures from the regulatory bodies and governments to reduce the prices of drugs could negatively impact pharmaceutical companies’ profitability. Furthermore, changes in approval processes could be challenging to the development of drugs. Moreover, severe competition from the other pharmaceutical companies regarding biosimilars and generics may be detrimental to the US pharmaceutical drug delivery market.

List of the prominent players in the US Pharmaceutical Drug Delivery Market:

• GlaxoSmithKline PLC
• Becton Dickinson and Company
• Pfizer Inc.
• Novartis International AG
• Hoffmann-La Roche AG
• Merck & Co. Inc.
• Sanofi S.A.
• Bayer Medicine Products AG
• 3M
• Others

The US Pharmaceutical Drug Delivery Market is segmented as follows:

By Route of Administration

• Oral
• Ocular
• Pulmonary
• Nasal
• Injectable
• Topical
• Others

By Application

• Cardiovascular Diseases
• Diabetes
• Cancer
• Infectious Diseases
• Others

By End-user

• Hospitals
• Ambulatory Services
• Home Healthcare